doi: 10.1093/ijnp/pyz052 169 Sifuentes-FrancoSSnchez-MacasDCCarrillo-IbarraSRivera-ValdsJJZuigaLYSnchez-LpezVA
The active pharmaceutical ingredient is the same, and the compounding process ensures consistent dosage in each injection
Label guidance is one capsule three times daily, totaling 1.5 g per day
To explore differences in (i) past-year use of GLP-1 or GLP-1/GIP medication to support weight loss and (ii) interest in using a weight-loss medication in the next year between population subgroups, we estimated these proportions stratified by gender, age, ethnicity, occupational social grade, financial situation, health-related economic inactivity, smoking status, alcohol consumption, past-month distress, and history of eating disorders
Research has demonstrated that Dihexa binds to HGF with remarkably high affinity (Kd = 65 picomolar) and acts as an allosteric modulator, potentiating HGF activity even at subthreshold concentrations